Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(4.19)
# 469
Out of 5,113 analysts
70
Total ratings
52.46%
Success rate
16.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Buy | $20 | $11.69 | +71.09% | 3 | Jan 29, 2026 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $15 → $25 | $13.82 | +80.90% | 6 | Jan 28, 2026 | |
| SRPT Sarepta Therapeutics | Reiterates: Sell | $5 | $21.31 | -76.54% | 3 | Jan 27, 2026 | |
| LEGN Legend Biotech | Maintains: Buy | $60 → $50 | $17.85 | +180.11% | 2 | Jan 22, 2026 | |
| AVTX Avalo Therapeutics | Reiterates: Buy | $25 | $14.97 | +67.00% | 2 | Jan 15, 2026 | |
| NGNE Neurogene | Reiterates: Buy | $70 | $19.27 | +263.26% | 4 | Jan 13, 2026 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $13 → $10 | $7.44 | +34.41% | 4 | Jan 13, 2026 | |
| ALMS Alumis | Reiterates: Buy | $20 → $40 | $27.71 | +44.35% | 3 | Jan 9, 2026 | |
| TIL Instil Bio | Downgrades: Neutral | n/a | $7.09 | - | 4 | Jan 7, 2026 | |
| EVMN Evommune | Initiates: Buy | $35 | $20.49 | +70.82% | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $60 | $56.68 | +5.86% | 3 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $72.83 | +23.58% | 5 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $20 → $45 | $24.03 | +87.27% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $7.76 | +157.73% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $30 | $7.28 | +312.09% | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $5.90 | +69.49% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $110 | $81.92 | +34.28% | 6 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $20 | $8.38 | +138.66% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $35.16 | +13.77% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $40 | $15.64 | +155.75% | 6 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $53.69 | +49.00% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.06 | +142.72% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $10.73 | +132.99% | 2 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $31.08 | -3.47% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.60 | +337.50% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $5.98 | -66.56% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.21 | +230.58% | 1 | Aug 11, 2025 |
Korro Bio
Jan 29, 2026
Upgrades: Buy
Price Target: $20
Current: $11.69
Upside: +71.09%
Intellia Therapeutics
Jan 28, 2026
Maintains: Buy
Price Target: $15 → $25
Current: $13.82
Upside: +80.90%
Sarepta Therapeutics
Jan 27, 2026
Reiterates: Sell
Price Target: $5
Current: $21.31
Upside: -76.54%
Legend Biotech
Jan 22, 2026
Maintains: Buy
Price Target: $60 → $50
Current: $17.85
Upside: +180.11%
Avalo Therapeutics
Jan 15, 2026
Reiterates: Buy
Price Target: $25
Current: $14.97
Upside: +67.00%
Neurogene
Jan 13, 2026
Reiterates: Buy
Price Target: $70
Current: $19.27
Upside: +263.26%
Lexeo Therapeutics
Jan 13, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $7.44
Upside: +34.41%
Alumis
Jan 9, 2026
Reiterates: Buy
Price Target: $20 → $40
Current: $27.71
Upside: +44.35%
Instil Bio
Jan 7, 2026
Downgrades: Neutral
Price Target: n/a
Current: $7.09
Upside: -
Evommune
Jan 6, 2026
Initiates: Buy
Price Target: $35
Current: $20.49
Upside: +70.82%
Dec 22, 2025
Maintains: Neutral
Price Target: $55 → $60
Current: $56.68
Upside: +5.86%
Dec 19, 2025
Reiterates: Buy
Price Target: $90
Current: $72.83
Upside: +23.58%
Dec 9, 2025
Upgrades: Buy
Price Target: $20 → $45
Current: $24.03
Upside: +87.27%
Nov 24, 2025
Initiates: Buy
Price Target: $20
Current: $7.76
Upside: +157.73%
Nov 19, 2025
Maintains: Buy
Price Target: $40 → $30
Current: $7.28
Upside: +312.09%
Nov 11, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $5.90
Upside: +69.49%
Nov 10, 2025
Maintains: Buy
Price Target: $100 → $110
Current: $81.92
Upside: +34.28%
Oct 27, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $8.38
Upside: +138.66%
Oct 27, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $35.16
Upside: +13.77%
Oct 21, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $15.64
Upside: +155.75%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $53.69
Upside: +49.00%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $2.06
Upside: +142.72%
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $10.73
Upside: +132.99%
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $31.08
Upside: -3.47%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.60
Upside: +337.50%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $5.98
Upside: -66.56%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.21
Upside: +230.58%